Reports

Ideas That Generate Results

Alembic Limited -  Company  Analysis

Alembic Limited - Company Analysis

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Nov, 2007| No. of Pages : 30

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 300.00
CD-ROM Mail Delivery
US$ 400.00
Hard Copy Mail Delivery
US$ 400.00
Electronic Access - Multi-User License
US$ 500.00

List of Figures:

Figure 2-1: Alembic Limited - Gross Revenue by Business Segment (in Million Rs), March 2006 & March 2007
Figure 2-2: Alembic Limited - Gross Revenue by Geographical Distribution (in Million Rs), March 2006 & March 2007
 
List of Tables:

Table 1-1: Alembic Limited - Ticker Codes at various Stock Exchanges
Table 1-2: Alembic Limited - Major Mergers & Acquisitions (2003 to 2007)
Table 1-3: Alembic Limited - Key Management People
Table 3-1: Alembic Limited - Financials Overview (in Million Rs), March 2007
Table 3-2: Alembic Limited - Breakup of Revenue & Sales (in Million Rs), March 2005 to March 2007
Table 3-3: Alembic Limited - Key Financial Ratios (March 2005 to March 2007)
Table 3-4: Alembic Limited - Earning & Income Estimates (in Thousand Rs), March 2005 to March 2007
Table 5-1: Ranbaxy Laboratories Limited - Key Financials (in Million Rs), 2004-2006
Table 5-2: Ranbaxy Laboratories Limited - SWOT Analysis
Table 5-3: Lupin Limited - Key Financials (in Million Rs), March 2005 to March 2007
Table 5-4: Lupin Limited - SWOT Analysis
Table 5-5: Cipla Limited - Key Financials (in Rs Crore), 2005-06 & 2006-07
Table 5-6: Cipla Limited - SWOT Analysis
Table 5-7: Zydus Cadila Healthcare Limited - Key Financials (in Million Rs), March 2004 to March 2006
Table 5-8: Zydus Cadila Healthcare Limited - SWOT Analysis
Table 5-9: Glaxo Smithkline Pharmaceuticals Limited - Key Financials (in Rs Lakh), 2005 & 2006
Table 5-10: Glaxo Smithkline Pharmaceuticals Limited - SWOT Analysis

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.